ESE-1 Regulates CREB-Mediated PTEN Expression to Activate the PI3K/Akt Pathway and Promote High-Glucose-Induced Endothelial Cell Injury

Abstract

Objective

Endothelial dysfunction is a central contributor to the vascular complications observed in individuals with diabetes. cAMP response element-binding protein (CREB) plays a crucial role in mediating hyperglycemia-induced endothelial dysfunction. Phosphatase and tensin homolog (PTEN) has been implicated in the regulation of endothelial inflammation, yet the precise mechanism by which CREB modulates PTEN to protect endothelial cells under high glucose conditions remains unknown. This study aims to elucidate this potential mechanism.

Methods

Human umbilical vein endothelial cells (HUVECs) were exposed to high glucose (30 mM) or normal glucose (5.5 mM) for 6 days. Cell viability and apoptosis were assessed via the Cell Counting Kit-8 and flow cytometry. To evaluate oxidative stress, the levels of reactive oxygen species (ROS), lactate dehydrogenase (LDH), and malondialdehyde (MDA) were measured via commercial assay kits. The interaction between CREB and endothelial specific molecule 1 (ESE-1) was assessed via coimmunoprecipitation. Chromatin immunoprecipitation and luciferase reporter assays were used to investigate the transcriptional regulation of PTEN by ESE-1 and CREB. Western blotting was performed to analyze the expression of intercellular adhesion molecule-1 and E-selectin. The adhesion of HUVECs was evaluated via monocyte‒endothelial cell adhesion assays.

Results

Our findings revealed a direct interaction between CREB and ESE-1, which together regulate PTEN expression to activate the phosphoinositide 3-kinase/protein kinase B pathway. Under high-glucose conditions, we observed significant increases in oxidative stress, inflammatory responses, and adhesion in HUVECs. ESE-1 knockdown reversed these effects, restoring endothelial cell function. Moreover, the overexpression of PTEN in high glucose–treated HUVECs rescued the endothelial injury induced by ESE-1 knockdown, suggesting that PTEN plays a pivotal role in mediating the protective effects.

Conclusion

ESE-1, through the regulation of CREB-mediated PTEN expression, activates the PI3K/AKT pathway and modulates key processes such as oxidative stress, inflammation, and adhesion in endothelial cells under high-glucose stress.

Keywords

Endothelial-specific molecule 1 / cAMP response element-binding protein / Phosphatase and tensin homolog / Phosphoinositide 3-kinase/protein kinase B pathway / High glucose / Endothelial cell injury

References

[1] Dal Canto E, Ceriello A, Rydén L, et al.. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol., 2019, 26(2_suppl): 25-32

[2] Eckel RH, Bornfeldt KE, Goldberg IJ. Cardiovascular disease in diabetes, beyond glucose. Cell Metab., 2021, 33(8): 1519-1545

[3] Kowalczuk A, Bourebaba N, Panchuk J, et al.. Calystegines Improve the Metabolic Activity of Human Adipose Derived Stromal Stem Cells (ASCs) under Hyperglycaemic Condition through the Reduction of Oxidative/ER Stress, Inflammation, and the Promotion of the AKT/PI3K/mTOR Pathway. Biomolecules., 2022, 12(3): 460

[4] Nedosugova LV, Markina YV, Bochkareva LA, et al.. Inflammatory Mechanisms of Diabetes and Its Vascular Complications. Biomedicines., 2022, 10(51168

[5] Banaszak M, Górna I, Woźniak D, et al.. The Impact of Curcumin, Resveratrol, and Cinnamon on Modulating Oxidative Stress and Antioxidant Activity in Type 2 Diabetes: Moving beyond an Anti-Hyperglycaemic Evaluation. Antioxidants (Basel)., 2024, 13(5510

[6] Yang T, Qi F, Guo F, et al.. An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory. Mol Med., 2024, 30(171

[7] Du XL, Edelstein D, Rossetti L, et al.. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A., 2000, 97(2212222-12226

[8] Wang N, Zhang C. Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease. Antioxidants (Basel)., 2024, 13(4): 455

[9] Li Y, Liu Y, Liu S, et al.. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Ther., 2023, 8(1152

[10] Domingueti CP, Dusse LM, Carvalho M, et al.. Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complications., 2016, 30(4738-745

[11] Chen CY, Chen J, He L, et al.. PTEN: Tumor Suppressor and Metabolic Regulator. Front Endocrinol (Lausanne)., 2018, 9: 338

[12] Naderali E, Khaki AA, Rad JS, et al.. Regulation and modulation of PTEN activity. Mol Biol Rep., 2018, 45(6): 2869-2881

[13] Lim HJ, Crowe P, Yang JL. Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer. J Cancer Res Clin Oncol., 2015, 141(4671-689

[14] Shen X, Chen X, Wang J, et al.. SET8 suppression mediates high glucose-induced vascular endothelial inflammation via the upregulation of PTEN. Exp Mol Med., 2020, 52(10): 1715-1729

[15] Li H, Zhu X, Zhang J, et al.. MicroRNA-25 inhibits high glucose-induced apoptosis in renal tubular epithelial cells via PTEN/AKT pathway. Biomed Pharmacother., 2017, 96: 471-479

[16] Lv Q, Xue Y, Li G, et al.. Beneficial effects of evodiamine on P2X(4)-mediated inflammatory injury of human umbilical vein endothelial cells due to high glucose. Int Immunopharmacol., 2015, 28(2): 1044-1049

[17] Feng Q, Li X, Qin X, et al.. PTEN inhibitor improves vascular remodeling and cardiac function after myocardial infarction through PI3k/Akt/VEGF signaling pathway. Mol Med., 2020, 26(1): 111

[18] Zhan Y, Yuan L, Kondo M, et al.. The counter-regulatory effects of ESE-1 during angiotensin II-mediated vascular inflammation and remodeling. Am J Hypertens., 2010, 23(121312-1317

[19] Longoni N, Sarti M, Albino D, et al.. ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression. Cancer Res., 2013, 73(14): 4533-4547

[20] Schauer IE, Knaub LA, Lloyd M, et al.. CREB downregulation in vascular disease: a common response to cardiovascular risk. Arterioscler Thromb Vasc Biol., 2010, 30(4): 733-741

[21] Suehiro J, Hamakubo T, Kodama T, et al.. Vascular endothelial growth factor activation of endothelial cells is mediated by early growth response-3. Blood., 2010, 115(12): 2520-2532

[22] Peshavariya HM, Liu GS, Chang CW, et al.. Prostacyclin signaling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis. Antioxid Redox Signal., 2014, 20(17): 2710-2725

[23] Akinyede KA, Oyewusi HA, Hughes GD, et al.. In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone Helichrysum petiolare Extract (AAHPE) with Molecular Docking Relevance in Diabetes Mellitus. Molecules., 2021, 27(1): 155

[24] Ho FM, Liu SH, Liau CS, et al.. High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation., 2000, 101(222618-2624

[25] Dou B, Zhu Y, Sun M, et al.. Mechanisms of Flavonoids and Their Derivatives in Endothelial Dysfunction Induced by Oxidative Stress in Diabetes. Molecules., 2024, 29(14): 3265

[26] Rudders S, Gaspar J, Madore R, et al.. ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-kappa B to regulate the inducible nitric-oxide synthase gene. J Biol Chem., 2001, 276(53302-3309

[27] Singh V, Kaur R, Kumari P, et al.. ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders. Clin Chim Acta., 2023, 548 117487

[28] Chong DLW, Rebeyrol C, José RJ, et al.. ICAM-1 and ICAM-2 Are Differentially Expressed and Up-Regulated on Inflamed Pulmonary Epithelium, but Neither ICAM-2 nor LFA-1: ICAM-1 Are Required for Neutrophil Migration Into the Airways In Vivo. Front Immunol., 2021, 12 691957

[29] Bozadjieva Kramer N, Lubaczeuski C, Blandino-Rosano M, et al.. Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia. Diabetes., 2021, 70(2): 477-491

[30] Yang J, Liu S, Wang H, et al.. miR-134-5p inhibition reduces infarct-induced cardiomyocyte apoptosis via Creb1 upregulation. J Stroke Cerebrovasc Dis., 2020, 29(8 104850

[31] Wu Q, Zhao Y, Duan W, et al.. Propofol inhibits high glucose-induced PP2A expression in human umbilical vein endothelial cells. Vascul Pharmacol., 2017, 91: 18-25

[32] Huang T, Li X, Wang F, et al.. The CREB/KMT5A complex regulates PTP1B to modulate high glucose-induced endothelial inflammatory factor levels in diabetic nephropathy. Cell Death Dis., 2021, 12(4): 333

[33] Song CL, Liu B, Shi YF, et al.. MicroRNA-130a alleviates human coronary artery endothelial cell injury and inflammatory responses by targeting PTEN via activating PI3K/Akt/eNOS signaling pathway. Oncotarget., 2016, 7(4471922-71936

[34] Zhu M, Chen J, Jiang H, et al.. Propofol protects against high glucose-induced endothelial adhesion molecules expression in human umbilical vein endothelial cells. Cardiovasc Diabetol., 2013, 12: 13

[35] Chen K, Li Y, Zhang X, et al.. The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates. Cell Death Dis., 2022, 13(5513

[36] Wang P, Tian X, Tang J, et al.. Artemisinin protects endothelial function and vasodilation from oxidative damage via activation of PI3K/Akt/eNOS pathway. Exp Gerontol., 2021, 147 111270

Funding

Natural Science Foundation of Xinjiang Uygur Autonomous Region(No.2020D01C210)

RIGHTS & PERMISSIONS

The Author(s), under exclusive licence to the Huazhong University of Science and Technology